INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 08, 2004 |
VP Clinical Programs
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,000 | -- | 500 |
| Oct 08, 2004 |
VP Clinical Programs
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 500 | -- | -- |
| Oct 08, 2004 |
VP Clinical Programs
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,626 | -- | -- |
| May 05, 2004 |
VP Clinical Programs
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 15,000 |
| Dec 15, 2003 |
VP, Clinical Sciences
|
VP, Clinical Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,077 | -- | 12,124 |
| Dec 15, 2003 |
VP, Clinical Sciences
|
VP, Clinical Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 |
| Dec 15, 2003 |
VP, Clinical Sciences
|
VP, Clinical Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.